2m 2m 2m 2m 2m 2m 2m
Corvus Pharmacet (CRVS)
NASDAQ
$10.67+$0.61 (+6.12%)
Price as of Oct 22, 2026 7:42 PM EDT- $845.4MMarket Cap
- 39.97%1-Year Change
- BiotechnologyIndustry
Corvus Pharmacet (CRVS)
$10.67+$0.61 (+6.12%)
CRVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.05 | ||
Change | -$0.18 (-1.76%) | ||
Open | $10.25 | ||
High | $10.59 | ||
Low | $10.00 | ||
Previous Close | $10.23 | ||
Volume | 868,812 | ||
30-Day Average Volume | 1,090,484 | ||
1-Week Change | 7.14% | ||
1-Month Change | -19.08% | ||
1-Year Change | 39.97% | ||
3-Year Change | 713.77% | ||
5-Year Change | 109.81% | ||
Fundamentals | |||
Shares Outstanding | 84.1M | ||
Total Assets | $239.3M | ||
Market Cap | $845.4M | ||
Enterprise Value | $826.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$16.0M | ||
EBIT | -$18.0M | ||
EBITDA | -$17.9M | ||
Net Working Capital | $207.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -53 | ||
PEG | 2 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue